Home > Healthcare > Medical Devices > Operating Room Supplies > Steerable Needles Market

Steerable Needles Market Trends

Report ID: GMI7063
Published Date: Oct 2023
Report Format: PDF

Download Free Sample

Steerable Needles Market Trends

Steerable needles are crucial in minimally invasive surgeries as they allow surgeons to navigate through tissues with precision, making them ideal for procedures in which small incisions are made. For instance, in laparoscopic surgeries, steerable needles can be used for tasks such as tissue biopsies or tumor ablations. Thus, rising use of steerable needles in minimally invasive procedures is said to augment the market progress.

Steerable needles are employed in various cancer treatments, such as RFA or cryoablation, wherein they help to deliver therapies directly into tumors. In brachytherapy, which was valued at USD 716 million in 2022, steerable needles are used to place radioactive sources precisely within or near the tumor site.
Therefore, as the demand and availability of steerable needles continue to grow, the need for steerable needles as a part of comprehensive medical care will also rise.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global steerable needles industry was valued at USD 1.3 billion in 2022 and is estimated to account for USD 2.5 billion by 2032, supported by the product

The bevel-tip flexible needles segment garnered USD 741 million revenue size in the year 2022 and will keep witnessing demand, attributed to their enhanced visibility, versatility, and established efficacy.

U.S. steerable needles market accounted for USD 497 million in 2022 and is predicted to witness substantial growth through 2032, owing to the annual increase in chronic diseases including breast cancer.

AprioMed, Inc., Merit Medical Systems, DEAM, Johnson & Johnson Services, Inc., Boston Scientific Corporation, Serpex Medical, Olympus Corporation, Medtronic, APT Medical Inc., Elekta Instrument AB and Terumo Corporation among others.